Innovating Transplantation,
Accelerating Research
Technology
Apersys AG has developed a unique
long-term organ perfusion platform, mimicking an ideal physiological environment, that is able to preserve and recover livers for transplantation.
About Us
Our team combines world leading
science in liver transplantation with
in-depth entrepreneurial expertise in medical devices.
Innovation
Discover the latest news, from the FDA Breakthrough Devices Designation to the recent publications in liver defatting.
Supported by
